| |
| |
|
| Insider
Information: |
Dp Vii Associates Lp |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
413,446 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,182,179 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
413,446 |
|
|
| Total
Value |
$7,182,179 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2011-12-22 |
50,643 |
2008-12-09 |
0 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-03-19 |
0 |
|
0 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2011-09-16 |
169,251 |
2010-11-29 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
51,013 |
2011-11-21 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2013-07-01 |
35,253 |
2013-07-01 |
0 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
2013-09-30 |
19,006 |
2013-09-30 |
0 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
54,390 |
2013-11-19 |
0 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
33,890 |
2014-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2011-09-16 |
4 |
B |
$2.00 |
$117,392 |
D/D |
58,696 |
169,251 |
2.45 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2010-11-29 |
4 |
B |
$4.00 |
$157,640 |
D/D |
39,410 |
110,555 |
2.45 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
10% Owner |
– – • |
2011-11-21 |
4 |
B |
$13.00 |
$203,125 |
D/D |
15,625 |
51,013 |
2.45 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2014-03-19 |
4 |
D |
$14.00 |
$710,402 |
D/D |
(50,743) |
0 |
0 |
- |
|
29 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
